BMS-914392

BMS-914392 · Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for BMS-914392, covering 2011-02-02 to 2015-10-12. Get the full timeline:

Most recent: Clinical Trial Update: Pacemaker Holter Assessment of the Effect of BMS-914392 on Atrial Fibrillation Burden [Phase 2]